Empower Advisory Group
NVO

Empower Advisory Group’s Novo Nordisk NVO Stock Holding History

Empower Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,817
Closed -$323K – 531
2025
Q3 		$323K Sell
5,817
-276
-5% -$16.2K ﹤0.01% 415
2025
Q2 		$421K Sell
6,093
-4,549
-43% -$309K ﹤0.01% 346
2025
Q1 		$739K Sell
10,642
-1,809
-15% -$149K ﹤0.01% 267
2024
Q4 		$1.07M Sell
12,451
-280
-2% -$30.3K ﹤0.01% 232
2024
Q3 		$1.52M Sell
12,731
-289
-2% -$38.5K 0.01% 209
2024
Q2 		$1.86M Buy
13,020
+77
+0.6% +$10.2K 0.01% 202
2024
Q1 		$1.66M Buy
12,943
+948
+8% +$113K 0.01% 210
2023
Q4 		$1.24M Buy
11,995
+1,582
+15% +$156K ﹤0.01% 225
2023
Q3 		$947K Sell
10,413
-1,333
-11% -$117K ﹤0.01% 233
2023
Q2 		$950K Buy
11,746
+450
+4% +$36.8K ﹤0.01% 238
2023
Q1 		$901K Buy
+11,296
New +$801K ﹤0.01% 247

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Empower Advisory Group's NVO Position: Q4 2025 in Review

Empower Advisory Group sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,817 shares — an estimated $323K sold.

Empower Advisory Group first reported a position in NVO in Q1 2023 and held it in 11 quarters. The position peaked at $1.86M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Empower Advisory Group reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Empower Advisory Group sold 5,817 Novo Nordisk shares in Q4 2025, an estimated $323K.
  • Empower Advisory Group first reported a position in Novo Nordisk in Q1 2023 and held it in 11 quarters.
  • Empower Advisory Group's Novo Nordisk position peaked at $1.86M in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Empower Advisory Group's 13F filing for Q4 2025, filed 12 Feb 2026.